The proton pump inhibitor medication class, which includes Esomeprazole, lowers the quantity of stomach acid produced. It treats Zollinger-Ellison syndrome, stomach ulcers, and gastroesophageal reflux disease (GERD). (overproduction of acid due to pancreatic tumor).
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Caution is advised when consuming alcohol with Exium Mups 20. Please consult your doctor.
Exium Mups 20 may be unsafe to use during pregnancy. Although there are limited studies on humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing them to you. Please consult your doctor.
Exium Mups 20 is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
It is not known whether Exium Mups 20 alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exium Mups 20 is safe to use in patients with kidney disease. No dose adjustment of Exium Mups 20 is recommended. However, inform your doctor if you have any kidney disease.
Exium Mups 20 should be used with caution in patients with severe liver disease. A dose adjustment may be needed. Please consult your doctor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. It is to be taken empty stomach.
Exium Mups 20 is a proton pump inhibitor (PPI). It works by reducing the amount of acid in the stomach which helps in the relief of acid-related indigestion and heartburn.
• Gastroesophageal Reflux Disease (GERD)
• Risk reduction in NSAID-associated gastric ulcer
• H. pylori Eradication
• Zollinger-Ellison syndrome and idiopathic hypersecretion
Esomeprazole may be a proton pump inhibitor that prevents the production of gastric acid by specifically impairing the H+/K+ ATPase found in the gastric parietal cell. By inhibiting the actions of an enzyme (H+/K+ ATPase or gastric proton pump), Exium Mups 20 aid in lowering stomach acid. This proton pump, which is located in the stomach wall cells, is in charge of releasing gastric acid secretion, which damages the duodenum, stomach, and food pipe tissues. Exium Mups 20 reduce the symptoms of gastroesophageal reflux disease (GERD), often known as heartburn, and esophagitis, an inflammation of the lining of the food pipe. The principal single optical isomer of proton pump inhibitors, esomeprazole (S-isomer of omeprazole), provides better corrosive control than racemic proton pump inhibitors.
Children aged 1 to 11:
Erosion of the Esophagus:
10 mg once daily for the maintenance of Erosive Esophagitis Healing
CYP2C19 and CYP3A4 substantially metabolize Exium Mups 20 in the liver. Esomeprazole is not expected to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1, and 3A4, according to in vitro and in vivo research. There shouldn't be any clinically significant interactions with medications that these CYP enzymes process. According to studies on drug interactions, esomeprazole does not interact clinically with phenytoin, warfarin, quinidine, clarithromycin, or amoxicillin. The main enzyme that metabolizes esomeprazole, CYP2C19, may be affected by esomeprazole. Diazepam's clearance was reduced by 45% when Esomeprazole 30 mg and diazepam, a CYP2C19 substrate, were taken together. Diazepam plasma levels have been seen to rise 12 hours after dosage and beyond. Esomeprazole reduces the production of stomach acid. As a result, esomeprazole may prevent the absorption of medications whose bioavailability is significantly influenced by gastrointestinal pH. (e.g., ketoconazole, iron salts, and digoxin)
Patients who have a history of recognized hypersensitivity to any formulation ingredient or to substituted Benzimidazoles should not take esomeprazole.
Pregnancy The S-isomer of omeprazole, esomeprazole, has not been adequately studied in pregnant women, and the available epidemiologic data do not support a link between first-trimester omeprazole use and an increased risk of significant congenital abnormalities or other negative pregnancy outcomes. The dosage-dependent embryo-lethality observed in reproduction tests in rats and rabbits occurred at omeprazole doses that ranged from 3.4 to 34 times the 40 mg oral human dose (based on a body surface area for a 60 kg person) There are no clinical studies on the effects of esomeprazole on breastfed infants or milk supply. Esomeprazole is the S-isomer of omeprazole, and limited evidence indicates that omeprazole may be found in human milk.
Along with the mother's clinical requirement for therapy and any potential negative effects on the breastfed child from treatment or from an underlying maternal ailment, the developmental and health benefits of nursing should be taken into consideration.
Store in a cool & dry place below 25º C, and protect from light.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.